Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Cancer Research
|
January 28, 2004
Identification and clinical relevance of receptor activator of nuclear factor kappaB ligand expression of myeloma cells
Ulrike Heider, Ivana Zavrski, Christian Jakob, et al.
British Journal of Haematology
|
April 30, 2003
Circulating hepatocyte growth factor levels in multiple myeloma
Christian Jakob, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Haematology
|
August 22, 2003
Bisphosphonates in early multiple myeloma
Orhan Sezer, Christian Jakob, Ivana Zavrski, et al.
Blood
|
November 9, 2002
RANK ligand and osteoprotegerin in myeloma bone disease
Orhan Sezer, Ulrike Heider, Ivana Zavrski, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
July 5, 2007
Molecular and clinical aspects of proteasome inhibition in the treatment of cancer
Ivana Zavrski, Christian Jakob, Martin Kaiser, et al.
Biochemical and Biophysical Research Communications
|
October 12, 2005
Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease
Ulrike Heider, Lorenz C Hofbauer, Ivana Zavrski, et al.
Biochemical and Biophysical Research Communications
|
June 7, 2005
Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function
Ivana Zavrski, Holger Krebbel, Britt Wildemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 13, 2006
Bone markers in multiple myeloma
Ulrike Heider, Claudia Fleissner, Ivana Zavrski, et al.
British Journal of Haematology
|
October 3, 2002
Serum levels of VEGF do not correlate with the severity of multiple myeloma
Christian Jakob, Ivana Zavrski, Ulrike Heider, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2006
Angiogenesis in multiple myeloma
Christian Jakob, Jan Sterz, Ivana Zavrski, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Cancer Research
|
January 28, 2004
Identification and clinical relevance of receptor activator of nuclear factor kappaB ligand expression of myeloma cells
Ulrike Heider, Ivana Zavrski, Christian Jakob, et al.
British Journal of Haematology
|
April 30, 2003
Circulating hepatocyte growth factor levels in multiple myeloma
Christian Jakob, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Haematology
|
August 22, 2003
Bisphosphonates in early multiple myeloma
Orhan Sezer, Christian Jakob, Ivana Zavrski, et al.
Blood
|
November 9, 2002
RANK ligand and osteoprotegerin in myeloma bone disease
Orhan Sezer, Ulrike Heider, Ivana Zavrski, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
July 5, 2007
Molecular and clinical aspects of proteasome inhibition in the treatment of cancer
Ivana Zavrski, Christian Jakob, Martin Kaiser, et al.
Biochemical and Biophysical Research Communications
|
October 12, 2005
Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease
Ulrike Heider, Lorenz C Hofbauer, Ivana Zavrski, et al.
Biochemical and Biophysical Research Communications
|
June 7, 2005
Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function
Ivana Zavrski, Holger Krebbel, Britt Wildemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 13, 2006
Bone markers in multiple myeloma
Ulrike Heider, Claudia Fleissner, Ivana Zavrski, et al.
British Journal of Haematology
|
October 3, 2002
Serum levels of VEGF do not correlate with the severity of multiple myeloma
Christian Jakob, Ivana Zavrski, Ulrike Heider, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2006
Angiogenesis in multiple myeloma
Christian Jakob, Jan Sterz, Ivana Zavrski, et al.
Page
of 3